Tech Company Financing Transactions
AMILI Funding Round
AMILI closed a $10.5 million Series A funding round on 6/15/2022. Investors included Pureland Global Venture, Seeds Capital and TVM Capital.
Transaction Overview
Company Name
Announced On
6/15/2022
Transaction Type
Venture Equity
Amount
$10,500,000
Round
Series A
Investors
Proceeds Purpose
The fresh funds will be used to accelerate the company's business expansion in Southeast Asia and Greater Asia.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
89 Science Park Dr. The Rutherford Lobby C Singapore Science 03-09
Singapore, 118261
Singapore
Singapore, 118261
Singapore
Phone
Website
Email Address
Overview
AMILI is Southeast Asia's first and only precision gut microbiome company. Founded by academic doctors and scientists, our aim is to advance microbiome research and apply this knowledge to improve human health. AMILI houses Southeast Asia's first and only gut microbiome transplant bank and is building up the world's largest multi-ethnic Asia gut microbiome database.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeremy Lim
Chief Scientific Officer
Jonathan Lee
Chief Technical Officer
Vivek Ravindran
VP - Bus. Development
Clifford Chow
VP - Bus. Development
Gwendoline Tan
VP - R & D
Toh Yee
VP - Regulatory Affairs
Saishreyas Sundarajoo
Browse more venture capital transactions:
Prev: 6/15/2022: Little Leaf Farms venture capital transaction
Next: 6/15/2022: Nue.io venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs